Cargando…

FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study

BACKGROUND: Reduced (18)F-fluorodeoxyglucose-positron emission tomography (FDG-PET) brain metabolism was recognized as a biomarker of neurodegeneration in the recently proposed ATN framework for Alzheimer’s disease (AD) biological definition. However, accumulating evidence suggested it is an indepen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ou, Ya-Nan, Xu, Wei, Li, Jie-Qiong, Guo, Yu, Cui, Mei, Chen, Ke-Liang, Huang, Yu-Yuan, Dong, Qiang, Tan, Lan, Yu, Jin-Tai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599313/ https://www.ncbi.nlm.nih.gov/pubmed/31253185 http://dx.doi.org/10.1186/s13195-019-0512-1

Ejemplares similares

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
por: Shen, Xue-Ning, et al.
Publicado: (2021)

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Metabolically healthy obesity reduces the risk of Alzheimer’s disease in elders: a longitudinal study
por: Ma, Ling-Zhi, et al.
Publicado: (2019)

Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia
por: Tan, Meng-Shan, et al.
Publicado: (2020)

Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
por: Guo, Yu, et al.
Publicado: (2021)

Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study
por: Wang, Hui‐Fu, et al.
Publicado: (2020)

Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
por: Ortner, Marion, et al.
Publicado: (2019)

Association between Life’s Simple 7 and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: the CABLE study
por: Zhao, Yong-Li, et al.
Publicado: (2022)

Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
por: Ortner, Marion, et al.
Publicado: (2020)

FDG-PET assessment of the locus coeruleus in Alzheimer’s disease
por: Liu, Kathy Y., et al.
Publicado: (2021)

FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

Fasting blood glucose and cerebrospinal fluid Alzheimer’s biomarkers in non-diabetic cognitively normal elders: the CABLE study
por: Ou, Ya-Nan, et al.
Publicado: (2020)

Sleep Dysregulation Is Associated with (18)F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease
por: Fernandes, Mariana, et al.
Publicado: (2023)

Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study
por: Teng, Lirong, et al.
Publicado: (2020)

The dynamics of plasma biomarkers across the Alzheimer’s continuum
por: Guo, Yu, et al.
Publicado: (2023)

Association of cerebrospinal fluid neurogranin levels with cognition and neurodegeneration in Alzheimer’s disease
por: Xue, Mei, et al.
Publicado: (2020)

Discordant Alzheimer's neurodegenerative biomarkers and their clinical outcomes
por: Guo, Yu, et al.
Publicado: (2020)

(18)F-FDG-PET in Mouse Models of Alzheimer's Disease
por: Bouter, Caroline, et al.
Publicado: (2019)

Disease trajectories in elders with suspected non-Alzheimer’s pathophysiology and its comparison with Alzheimer’s disease pathophysiology: a longitudinal study
por: Li, Jie-Qiong, et al.
Publicado: (2023)

Myocarditis on (18)FDG-PET imaging
por: Chaaban, Nourhan, et al.
Publicado: (2022)

Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study
por: Ou, Ya-Nan, et al.
Publicado: (2021)

Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology
por: Laforce, Robert, et al.
Publicado: (2014)

Biological characteristics of (18)F-FDG PET/CT imaging of cerebral alveolar echinococcosis
por: Yibulayin, Amina, et al.
Publicado: (2018)

The Use of F-18 FDG PET-Based Cognitive Reserve to Evaluate Cognitive Decline in Alzheimer’s Disease, Independent of Educational Influence
por: Choi, Hyung Jin, et al.
Publicado: (2023)

Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
por: Levin, Fedor, et al.
Publicado: (2021)

Association of peripheral immunity with cognition, neuroimaging, and Alzheimer’s pathology
por: Hou, Jia-Hui, et al.
Publicado: (2022)

Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Uterine Intravenous Leiomyomatosis with Intracardiac Extension and Pulmonary Benign Metastases on FDG PET/CT: A Case Report
por: Wang, Hui-Chun, et al.
Publicado: (2016)

Comparison of the clinical impact of 2-[(18)F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer’s disease
por: Gjerum, Le, et al.
Publicado: (2021)

FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2023)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

Neural Correlates of Stroop Performance in Alzheimer's Disease: A FDG-PET Study
por: Yun, Je-Yeon, et al.
Publicado: (2011)

Generative FDG-PET and MRI Model of Aging and Disease Progression in Alzheimer's Disease
por: Dukart, Juergen, et al.
Publicado: (2013)

Broad learning for early diagnosis of Alzheimer's disease using FDG-PET of the brain
por: Duan, Junwei, et al.
Publicado: (2023)

Deep learning-based amyloid PET positivity classification model in the Alzheimer’s disease continuum by using 2-[(18)F]FDG PET
por: Kim, Suhong, et al.
Publicado: (2021)

High expression of HNRNPR in ESCA combined with (18)F-FDG PET/CT metabolic parameters are novel biomarkers for preoperative diagnosis of ESCA
por: Liu, Xiao-Yu, et al.
Publicado: (2022)

High pulse pressure is a risk factor for prodromal Alzheimer’s disease: a longitudinal study
por: Shi, Wen-Yan, et al.
Publicado: (2020)

Potential Usefulness of FDG PET/CT in Patients with Sepsis of Unknown Origin
por: Tseng, Jing-Ren, et al.
Publicado: (2013)

Longitudinal tau PET in ageing and Alzheimer’s disease
por: Jack, Clifford R, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0n30apjs8ocq17t2e4v7cb1kh2